Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Kobayashi Launches 7 New Products
August 4, 2008
- Councils for Promotion of Use of Generics Created by 30 Prefectures
August 4, 2008
- Paltac KS to Report Profits This Fiscal Year
August 4, 2008
- More Doctors Concerned about Quality of Generics Based on Their Own Experience
August 4, 2008
- Miconazole, Emedastine Fumarate Classified into Class 1 OTC Drugs
August 4, 2008
- GENERICS NEWS IN BRIEF
August 4, 2008
- Updating Reduces Number of Class 1 OTC Drugs from 23 to 21
August 4, 2008
- Fuji Yakuhin Developing Drug for Gout at PII
August 4, 2008
- SELF-MEDICATION NEWS IN BRIEF
August 4, 2008
- Novartis to Apply for Everolimus for RCC within 2008
August 4, 2008
- JMA Opposed to Performance-Oriented Medical Fees
August 4, 2008
- R&D NEWS IN BRIEF
August 4, 2008
- Majority of People Have a Bad Image of Morphine: Palliative Care Survey
August 4, 2008
- No Additional Safety Measures Needed for Zetia, Comtan: EPPV
August 4, 2008
- Patients Should Speak out to Improve the Quality of Healthcare
August 4, 2008
- Korosho Calls For Precautions on Use of Risedronate
August 4, 2008
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
August 4, 2008
- Roche Acquires Mirus to Advance RNAi Delivery Research
August 4, 2008
- Negative Primary Balance of \3.9 Tril. Projected in FY2011
August 4, 2008
- Erbitux to Enhance Merck Serono's Presence in Japan
August 4, 2008
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…